17 research teams aiming to elucidate cancer biology

17 research teams aiming to elucidate cancer biology

Make discoveries that will lead to new diagnostic and therapeutic tools.

Address issues emerging from the latest advances in international cancer research and drive innovations for the benefit of patients.
The CRCM is one of the leading centers of biomedical research in France

The CRCM is one of the leading centers of biomedical research in France

Getting scientists and clinicians to work together on a daily basis to address critical issues in cancer biology.

Pr JP. Borg, Director of the CRCM
and Scientific Director of Institut Paoli-Calmettes
17 research teams aiming to elucidate cancer biology

17 research teams aiming to elucidate cancer biology

Make discoveries that will lead to new diagnostic and therapeutic tools.

Address issues emerging from the latest advances in international cancer research and drive innovations for the benefit of patients.
The CRCM is one of the leading centers of biomedical research in France

The CRCM is one of the leading centers of biomedical research in France

Getting scientists and clinicians to work together on a daily basis to address critical issues in cancer biology.

Pr JP. Borg, Director of the CRCM
and Scientific Director of Institut Paoli-Calmettes
17 research teams aiming to elucidate cancer biology

17 research teams aiming to elucidate cancer biology

Make discoveries that will lead to new diagnostic and therapeutic tools.

Address issues emerging from the latest advances in international cancer research and drive innovations for the benefit of patients.
The CRCM is one of the leading centers of biomedical research in France

The CRCM is one of the leading centers of biomedical research in France

Getting scientists and clinicians to work together on a daily basis to address critical issues in cancer biology.

Pr JP. Borg, Director of the CRCM
and Scientific Director of Institut Paoli-Calmettes
17 research teams aiming to elucidate cancer biology

17 research teams aiming to elucidate cancer biology

Make discoveries that will lead to new diagnostic and therapeutic tools.

Address issues emerging from the latest advances in international cancer research and drive innovations for the benefit of patients.
The CRCM is one of the leading centers of biomedical research in France

The CRCM is one of the leading centers of biomedical research in France

Getting scientists and clinicians to work together on a daily basis to address critical issues in cancer biology.

Pr JP. Borg, Director of the CRCM
and Scientific Director of Institut Paoli-Calmettes
17 research teams aiming to elucidate cancer biology

17 research teams aiming to elucidate cancer biology

Make discoveries that will lead to new diagnostic and therapeutic tools.

Address issues emerging from the latest advances in international cancer research and drive innovations for the benefit of patients.
FightCancer : support from European Union

FightCancer : support from European Union

FightCancer : Creating a translational research center dedicated to pancreatic cancer and targeted therapeutic and deciphering the molecular mechanisms involved in resistance and recurrence of poor prognosis tumors.

Latest News

Tuesday 26 July 2016

Appel à candidatures pour l'accueil de chercheurs en résidence


More

Event

From Tuesday, Sep 6th 2016 at 01:00 PM
To Saturday, Aug 6th 2016 at 01:00 PM
Organized by Daniel Olive

Antonio Cosma


Read more

Highlighted publications

Nature, Nat Commun, ACS Chem Biol, Genome Research, Dev Cell: our 5 latest publications

 

Sliding sleeves of XRCC4–XLF bridge DNA and connect fragments of broken DNA Ineke Brouwer,...


More

Keynote Lectures

On Tuesday, Sep 13th 2016 at 11:00 AM
Organized by Géraldine Guasch

Cédric Blanpain: Cancer cells of origin and tumor heterogeneity


Read more

About the CRCM, Cancer Research Center of Marseille

The Centre de Recherche en Cancérologie de Marseille (CRCM, Cancer Research Center of Marseille) affiliated to Inserm (UMR1068), CNRS (UMR7258) and Aix-Marseille University (UM105) is an original center in the landscape of French research. This originality is not only due to its location in the heart of the Institut Paoli-Calmettes (IPC) but also to his vocation: to advance the biology and medicine of cancer while working at the physiological and pathological interface, the fundamental and the applied, research and the clinic. This continuum between basic research, translational research and clinical research is really the hallmark of the CRCM. As an example, most of our publications are co-authored by scientists and clinicians, which is far from the norm in our discipline.

We explore communication networks (signals, surface receptors, communication nodes...) that regulate the action of cancer cells and immune cells and seek to identify genetic alterations (from point mutations of a gene to complex chromosomal abnormalities) leading to the transformation of  a healthy cell into a tumor cell.

This work has already helped improve our understanding of the disease, to better understand how immune cells fight it and the strategies used by tumor cells in an attempt to escape them. They also led to the discovery of new molecular targets that are now the subject of diagnostic and therapeutic applications in oncology.

As a consequence of its new organization implemented in 2012, the CRCM has enriched both its research and its application areas to ensure better and faster understanding, diagnosis and treatment disease.

The CRCM is:

250 people (scientists, professors, clinicians, engineers, technicians, administrative staff and PhD student)

 

8000 sq. meters of lab space

 

17 teams dedicated to research working in close collaboration with IPC's clinical teams

Their main scientific and medical specialties are 1) the molecular basis of oncogenesis and tumour dissemination and 2) the development of innovative therapeutic innovations for breast cancers, pancreatic cancer and malignant hemopathies.

More info about our research teams

 

Our technological platforms where clinicians and scientists at the IPC and the CRCM work together on a daily basis

To conduct their research but also improve the daily diagnosis, treatment and monitoring of patients, clinicians and scientists at the IPC and the CRCM enjoy engineering and advanced technology platforms that cover all models and scales of analysis.

More info about our technological platforms